We therefore aimed to identify the effects of FGF23 independent of kidney disease by studying a prospective cohort with normal kidney function, but with CV risk factors that included diabetes, hypertension, and hyperlipidemia. This evidence concerns the gene FGF23 and diabetes mellitus.